Granules India Limited has informed the Exchange regarding a press release dated January 13, 2021, titled "Granules India Limited announces USFDA approval of Metformin Hydrochloride ER Tablets USP, 500 mg and 1000 mg".
Press Release Jan 13 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Granules India
- Press Release Dec 03 2020
- Press Release Oct 22 2020
- Press Release Sep 25 2020
- Press Release Sep 11 2020
Later from Granules India
- Press Release Feb 01 2021
- Press Release Feb 17 2021
- Press Release Feb 24 2021
- Press Release Jul 21 2021
- Press Release Aug 30 2021
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India